Expression and genetic profiling for treatment and classification of dlbcl
AssigneeGenomic Testing Cooperative, LCA
InventorMaher Albitar
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenomic Testing Cooperative, LCA
InventorMaher Albitar
Estimating the term…
A method of treating diffuse large B-cell lymphoma, comprises obtaining a sample from a patient having diffuse large B-cell lymphoma; detecting in the sample, by an assay, mutation in each gene in a first panel; quantifying in the sample an expression level of each gene in a second panel; classifying the diffuse large B-cell lymphoma of the patient as having a cell of origin of either (i) germinal-center B-cell-like or (ii) activated B-cell-like; and treating the patient with a cancer treatment therapy regime. The first panel comprises at least one gene selected from the group consisting of EZH1 and MYD88; and the second panel comprises at least one gene selected from the group consisting of IRF4, MYBL1, RASGRF1, S1PR2 and SSBP2.
A method of treating diffuse large B-cell lymphoma, comprising:
A method, comprising:
A method, comprising:
A method, comprising:
Dependencies are inferred from the claim text.